The long-term benefits of bariatric surgery in elderly and super-obese populations.


Journal

Revista espanola de enfermedades digestivas
ISSN: 1130-0108
Titre abrégé: Rev Esp Enferm Dig
Pays: Spain
ID NLM: 9007566

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 5 3 2019
medline: 15 5 2020
entrez: 5 3 2019
Statut: ppublish

Résumé

to assess the long-term benefits of bariatric surgery in super-obese (body mass index [BMI] ≥ 50) and in elderly obese (age > 60 years) populations. one hundred and twenty one patients who underwent laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy in a university hospital were retrospectively subdivided into the following groups: BMI < 50 vs ≥ 50 and age < 60 vs ≥ 60 years. Weight loss, body composition and comorbidity outcomes were registered after one and six months and one, two, three and five years with 100%, 93%, 89%, 80%, 75% and 60% successful follow-up. the percentage of excess BMI loss (%EBMIL) was comparable between BMI groups and age groups and the difference in the long-term follow up was not statistically significant (p > 0.05). Complication rates, comorbidity resolution, reduction in body fat and increase in fat-free mass were comparable between BMI groups and age groups. Gastric bypass resulted in a greater weight loss compared to sleeve gastrectomy. The % EBMIL was 65.2% vs 46.7% (p = 0.002), 65.8% vs 44.9% (p = 0.004), 64.4% vs 30.5% (p = 0.001), 55.6% vs 17.6% (p = 0.016) at one, two, three and five years postoperative, respectively. Similarly, in the super-obese group, weight loss was more pronounced after gastric bypass versus sleeve gastrectomy. bariatric surgery in super-obese and elderly populations is an effective and safe weight loss measure with a good comorbidity resolution in the long-term. Gastric bypass is superior to sleeve gastrectomy in terms of long-term weight loss and comorbidity resolution in all the groups investigated.

Identifiants

pubmed: 30829531
doi: 10.17235/reed.2019.5917/2018
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

371-377

Auteurs

Linas Martinaitis (L)

Cirugía General y Digestiva, Clínica Universidad de Navarra, España.

Carlota Tuero (C)

General Surgery, Clínica Universidad de Navarra, España.

Manuel Fortún Landecho (M)

Department of Internal Medicine, Clínica Universidad de Navarra, España.

Javier A Cienfuegos (JA)

General Surgery, Clínica Universidad de Navarra, España.

Rafael Moncada (R)

Department of Anesthesiology, Clínica Universidad de Navarra.

Fernando Rotellar (F)

General Surgery, Clínica Universidad de Navarra, España.

Camilo Silva (C)

Department of Endocrinology, Clínica Universidad de Navarra, España.

Gema Frühbeck (G)

Department of Endocrinology, Clínica Universidad de Navarra, España.

Víctor Valentí (V)

General Surgery, Clínica Universidad de Navarra, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH